Tech Coast Angels Puts $3.2M into Savara Pharmaceuticals
Tech Coast Angels has $3.2 million to a Savara Pharmaceuticals Series B financing. This markes the largest single funding ever raised by the TCA network. Savara is focused on the treatment of pulmonary methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients.
20 March 2013•2 mins read
